Cathal Coyle (C Coyle)

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 7

Top Topics

Top Venues

Alimentary pharmacology & therapeutics

Drug development and industrial pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Shirley Sonmez, Cathal Coyle, Daniel Sifrim, Philip Woodland
Duration of adhesion of swallowed alginates to distal oesophageal mucosa: implications for topical therapy of oesophageal diseases. Alimentary pharmacology & therapeutics 52 (3) (2020)
Zheng Feei Ma, Mohd Adli Deraman, Cathal Coyle, Yeong Yeh Lee
Editorial: simultaneous, prolonged monitoring of the acid pocket and oesophageal reflux. Authors' reply. Alimentary pharmacology & therapeutics 52 (2) (2020)
Mohd Adli Deraman, Muhammad Ilham Abdul Hafidz, Rona Marie Lawenko, Zheng Feei Ma, Mung Seong Wong, Cathal Coyle, Yeong Yeh Lee
Randomised clinical trial: the effectiveness of Gaviscon Advance vs non-alginate antacid in suppression of acid pocket and post-prandial reflux in obese individuals after late-night supper. Alimentary pharmacology & therapeutics 51 (11) (2020)
Cathal Coyle, Russell Symonds, Jane Allan, Sarah Dawson, Sheldon Russell, Adam Smith, Colin Daff, Helen Kotze
Sustained proton pump inhibitor deprescribing among dyspeptic patients in general practice: a return to self-management through a programme of education and alginate rescue therapy. A prospective interventional study. BJGP open 3 (3) (2019)
Joanne Wilkinson, Khalid Abd-Elaziz, Izaak den Daas, Johan Wemer, Michiel van Haastert, Victoria Hodgkinson, Michelle Foster, Cathal Coyle
Two placebo-controlled crossover studies in healthy subjects to evaluate gastric acid neutralization by an alginate-antacid formulation (Gaviscon Double Action). Drug development and industrial pharmacy 45 (3) (2018)
Cathal Coyle, P Bytzer
Editorial: refractory GERD-good drug, wrong patients? Authors' reply. Alimentary pharmacology & therapeutics 46 (2) (2017)
Cathal Coyle, G Crawford, J Wilkinson, S J Thomas, P Bytzer
Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms. Alimentary pharmacology & therapeutics 45 (12) (2017)